Amgen
Amgen officials report on new developments
Published in MD Week, September 7th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Amgen.
Report 1: Amgen (NASDAQ:AMGN) today submitted testimony for the record of the House Ways & Means Subcommittee on Health hearing on "Ensuring Kidney Patients Receive Safe and Appropriate Anemia Management Care."
Amgen cited data in its testimony showing that the majority of EPOGEN(R) (Epoetin alfa) use in dialysis has been and continues to be appropriate. When examined over time, 83 percent of patient hemoglobin excursions above 12 g/dL fall below 12 g/dL within three...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of MD Week
Source: MD Week (2007-09-07)
More Articles from MD Week
- Angiology
Anesiva Receives FDA Approval for Zingo, a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children - Bioengineering
Demand for DNA Repair Formula Drives Growth of Remergent Brand - Biomedicine
Brain Gene Flicks the Switch on Gender - Biomedicine
HealthGate Helps Hospitals Address Medicare's End of Coverage for Preventable Errors - Breast Cancer
New findings from Medical Academy in the area of breast cancer published - Cardiology
Adverse reactions to rosiglitazone (Avandia, Avandamet, Avaglim) - More from this issue of MD Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
